Study of the efficiency and safety of Ladasten therapy in patients with cardiovascular disease

A trial was carried out to study the efficiency and safety of therapy with the new antiasthenic drug Ladasten. The findings suggest its high safety and efficiency and good tolerability of Ladasten in the treatment of asthenia and asthenic spectrum disorders, the development of which is associated wi...

Full description

Bibliographic Details
Main Authors: F. Yu Kopylov, Yu. M Nikitina, E. A Makukh, A. L Syrkin
Format: Article
Language:English
Published: Concilium Medicum 2010-03-01
Series:КардиоСоматика
Subjects:
Online Access:https://cardiosomatics.orscience.ru/2221-7185/article/view/44966
_version_ 1818616004151869440
author F. Yu Kopylov
Yu. M Nikitina
E. A Makukh
A. L Syrkin
author_facet F. Yu Kopylov
Yu. M Nikitina
E. A Makukh
A. L Syrkin
author_sort F. Yu Kopylov
collection DOAJ
description A trial was carried out to study the efficiency and safety of therapy with the new antiasthenic drug Ladasten. The findings suggest its high safety and efficiency and good tolerability of Ladasten in the treatment of asthenia and asthenic spectrum disorders, the development of which is associated with cardiovascular disease.
first_indexed 2024-12-16T16:42:54Z
format Article
id doaj.art-94d0b505957d439aa1b4ef14e954834d
institution Directory Open Access Journal
issn 2221-7185
2658-5707
language English
last_indexed 2024-12-16T16:42:54Z
publishDate 2010-03-01
publisher Concilium Medicum
record_format Article
series КардиоСоматика
spelling doaj.art-94d0b505957d439aa1b4ef14e954834d2022-12-21T22:24:16ZengConcilium MedicumКардиоСоматика2221-71852658-57072010-03-0111576140632Study of the efficiency and safety of Ladasten therapy in patients with cardiovascular diseaseF. Yu KopylovYu. M NikitinaE. A MakukhA. L SyrkinA trial was carried out to study the efficiency and safety of therapy with the new antiasthenic drug Ladasten. The findings suggest its high safety and efficiency and good tolerability of Ladasten in the treatment of asthenia and asthenic spectrum disorders, the development of which is associated with cardiovascular disease.https://cardiosomatics.orscience.ru/2221-7185/article/view/44966cardiovascular pathologyastheniaantiasthenic means
spellingShingle F. Yu Kopylov
Yu. M Nikitina
E. A Makukh
A. L Syrkin
Study of the efficiency and safety of Ladasten therapy in patients with cardiovascular disease
КардиоСоматика
cardiovascular pathology
asthenia
antiasthenic means
title Study of the efficiency and safety of Ladasten therapy in patients with cardiovascular disease
title_full Study of the efficiency and safety of Ladasten therapy in patients with cardiovascular disease
title_fullStr Study of the efficiency and safety of Ladasten therapy in patients with cardiovascular disease
title_full_unstemmed Study of the efficiency and safety of Ladasten therapy in patients with cardiovascular disease
title_short Study of the efficiency and safety of Ladasten therapy in patients with cardiovascular disease
title_sort study of the efficiency and safety of ladasten therapy in patients with cardiovascular disease
topic cardiovascular pathology
asthenia
antiasthenic means
url https://cardiosomatics.orscience.ru/2221-7185/article/view/44966
work_keys_str_mv AT fyukopylov studyoftheefficiencyandsafetyofladastentherapyinpatientswithcardiovasculardisease
AT yumnikitina studyoftheefficiencyandsafetyofladastentherapyinpatientswithcardiovasculardisease
AT eamakukh studyoftheefficiencyandsafetyofladastentherapyinpatientswithcardiovasculardisease
AT alsyrkin studyoftheefficiencyandsafetyofladastentherapyinpatientswithcardiovasculardisease